Literature DB >> 15269625

Comparison of longstanding pediatric-onset and adult-onset Crohn's disease.

Hugh J Freeman1.   

Abstract

INTRODUCTION: Limited information is available on the characteristics of longstanding Crohn's disease with onset in childhood or adolescence.
MATERIALS AND METHODS: In this retrospective study, 224 patients with pediatric-onset Crohn's disease were compared to a group of patients with disease diagnosed as adults.
RESULTS: More than 50% of the patients in the pediatric-onset group were followed for more than a decade, with a mean follow-up of 12.2 years. There were 96 male (42.9%) and 128 female (57.1%) patients. Most had disease diagnosed in adolescence. The female predominance, similar to adult-onset disease, was noted only among patients with disease diagnosed in adolescence (13-19 years), not in childhood. Disease most often involved both ileum and colon (128 of 224; 57.1%). Isolated ileal or colonic disease was less common. Upper gastrointestinal tract disease was present in 42 of 224 (18.8%) patients. The incidence of strictures (28.6%) and penetrating complications (46.4%) was similar to that of adults followed for the same period of time.
CONCLUSION: In pediatric-onset Crohn's disease, female-predominance emerges during adolescence. Pediatric-onset disease is more extensive than adult-onset disease. When followed for an extended period of time, it has high rates of disease complexity, with strictures and penetrating complications similar to adult-onset disease.

Entities:  

Mesh:

Year:  2004        PMID: 15269625     DOI: 10.1097/00005176-200408000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

Review 1.  Inflammatory bowel disease.

Authors:  R M Beattie; N M Croft; J M Fell; N A Afzal; R B Heuschkel
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

3.  Granuloma-positive Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  Long-term natural history of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 5.  Natural history and long-term clinical course of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.

Authors:  Neera Gupta; Alan G Bostrom; Barbara S Kirschner; George D Ferry; Benjamin D Gold; Stanley A Cohen; Harland S Winter; Robert N Baldassano; Oren Abramson; Terry Smith; Melvin B Heyman
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

7.  Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype.

Authors:  Ron Shaoul; Amir Karban; Shimon Reif; Batia Weiss; Raanan Shamir; Ada Tamir; Ofir Davidovich; Jonathan Halevi; Esther Leshinsky Silver; Arie Levine
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

8.  Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Can J Gastroenterol Hepatol       Date:  2015-05-21

9.  Outcomes of Pediatric Fistulising Perianal Crohn's Disease.

Authors:  Bilge S Akkelle; Ozlem K Sengul; Burcu Volkan; Engin Tutar; Rabia Ergelen; Samet Yardimci; Deniz Ertem
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

10.  Efficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn's complex fistula: a Phase IV clinical study.

Authors:  Yu Jeong Cho; Hyunhee Kwon; Yong Jae Kwon; Kyung Mo Kim; Seak Hee Oh; Dae Yeon Kim
Journal:  Ann Surg Treat Res       Date:  2021-06-30       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.